Announcement

Collapse
No announcement yet.

Am J Case Rep . Short-Term Corticosteroid Therapy for Early Exacerbation of COVID-19 Pneumonia: A Case Report

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Am J Case Rep . Short-Term Corticosteroid Therapy for Early Exacerbation of COVID-19 Pneumonia: A Case Report


    Am J Case Rep


    . 2020 Aug 14;21:e924476.
    doi: 10.12659/AJCR.924476.
    Short-Term Corticosteroid Therapy for Early Exacerbation of COVID-19 Pneumonia: A Case Report


    Akira Urano 1 , Hajime Kasai 1 2 3 , Yushi Murai 1 , Hideki Ikeda 1 , Takashi Urushibara 1 4



    Affiliations

    Abstract

    BACKGROUND The effect of corticosteroids in the management of patients with coronavirus disease 2019 (COVID-19) is unclear. CASE REPORT A 67-year-old man who tested positive for COVID-19 by reverse-transcription PCR (RT-PCR) analysis was admitted to our hospital. On admission, he had no dyspnea and his oxygen saturation (SpO₂) level was normal. Chest imaging revealed ground-glass opacities (GGO) distributed in both lung fields. Four days after admission, bilateral lung shadows worsened, with a slight reduction in SpO₂ levels. Short-term corticosteroid therapy was initiated, and SpO₂ and radiographic findings promptly improved without use of antiviral agents. CONCLUSIONS More data are required to ascertain the role of corticosteroids in the management of COVID-19 pneumonia.


Working...
X